HIGH FLOW NASAL OXYGEN THERAPY (HFNO) IN OPPOSITION TO NON-INVASIVE MECHANICAL VENTILATION (NIV) ADVANTAGES, DISADVANTAGES AND THEIR USE IN COVID-19 INFECTION: BRIEF REVIEW

Radmila Dmitrovic, Biljana Lazovic, Isidora Simonovic

Abstract


In the last few decades, different devices for oxygen application have become available, such as low flow systems, high flow systems (HFNO), and non-invasive ventilation (NIV). They are widely applicable and have many advantages as well as disadvantages. HFNO modalities decrease dead space, improve alveolar ventilation, and apply oxygen up to 60l / min, delivering it humidified and heated opposite NIV, which increases anatomical dead space, maintains adequate minute ventilation, and is used in more conditions than HFNO, etc. In our research, we included 12 articles. The study was conducted using literature published up from 2013 to July 2020. In our research we used following keywords: 'non-invasive ventilation', 'high-flow nasal oxygen', 'advantages', 'disadvantages', 'COVID-19'.

 The HFNO system appears to be more successful than standard oxygen treatment and non-inferior to NIV. It is simple, easy to apply but still insufficiently researched. More research is needed in the future on the benefits and disadvantages of the HFNO system.


Keywords


HFNO, NIV, COVID19, advantages, disadvantages

Full Text:

PDF

References


Renda T, Corrado A, Iskandar G, Pelaia G, Abdala K, Navalesi P. High-flow nasal oxygen therapy in intensive care and anesthesia. Br J Anaesth. 2018;120(1):18-27. doi: 10.1016/j.bja.2017.11.010.

Dres M, Demoule A. What every intensivist should know about using high-flow nasal oxygen for critically ill patients. Rev Bras Ter Intensiva. 2017;29(4):399-403. doi: 10.5935/0103-507X.20170060.

Lazovic B, Dmitrovic R, Simonovic I, Esquinas AM. Baseline physiological measurements: respiratory rate, spontaneous breathing, respiratory effort, and work of breathing. In: Esquinas AM. Principles and practices of non-invasive mechanical ventilation monitoring. From intensive care to home care. New York: Nova Science Publisher; 2021. p. 01-07.

Ivanovic M, Petrovic J, Miletic M, Danicic A, Bojovic B, Vukcevic M, et al. Rib-cage-movement measurements as a potential new trigger signal in non-invasive mechanical ventilation. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:4511-4. doi: 10.1109/EMBC.2015.7319397.

Dolinaj V, LonÄar T, Božić T, KariÅ¡ik M, Marković D, Janjević D. Neinvazivna mehaniÄka ventilacija pluća. SJAIT. 2014;36(1-2):97-101.

Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016; 61(4): 529-41. doi: 10.4187/respcare.04577.

Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S et al.High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-96. doi: 10.1056/NEJMoa1503326.

Jaber S, Monnin M, Girard M, Conseil M, Cisse M, Carr J et al. Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-center, blinded, randomized controlled OPTINIV trial. Intensive Care Med. 2016;42(12):1877-87. doi: 10.1007/s00134-016-4588-9.

Frat JP, J Ragot S, Girault C, Perbet S, Prat G, Boulain T et al. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: post hoc analysis of a randomized trial. Lancet Respir Med. 2016;4(8):646-52. doi: 10.1016/S2213-2600(16)30093-5.

Spicuzza L, Schisano M. High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future. Ther Adv Chronic Dis. 2020;11: 2040622320920106. doi: 10.1177/2040622320920106.

Van der Slujis AF. Non-invasive ventilation; PROs and CONs. Neth J Crit Care. 2013;17(2):27-9.

Northern Devon Healthcare. Guidelines for high flow nasal oxygen therapy (HFNO) on General Wards. Available from:https://www.northdevonhealth.nhs.uk/wpcontent/uploads/2020/05/Guidelines-for-High-Flow-Oxygen-Therapy-AIRVO%C2%B2-Final-v2.0.pdf [cited by 26.12.2020.]

Kaya AG, Oz M, Erol S, Ciftci F, Ciledag A, Kaya A. High flow nasal cannula in COVID-19: a literature review. Tuberk Toraks. 2020;68(2):168-74. doi: 10.5578/tt.69807.

Winck JC, Ambrosino N. Covid-19 pandemic and non-invasive respiratory management: every Goliath needs a David. An evidence-based evaluation of problems. Pulmonology. 2020;26(4):213-20. doi: 10.1016/j.pulmoe.2020.04.013.




DOI: http://dx.doi.org/10.24125/sanamed.v16i3.526

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Radmila Dmitrovic, Biljana Lazovic, Isidora Simonovic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.